跳至主要内容
临床试验/CTRI/2017/08/009576
CTRI/2017/08/009576招募中2 期

A prospective open labeled randomized clinical trial on "Kalladaippu" (Urolithiasis) with evaluation of trial drug "Siru Nerunjil kudineer"

S Neelavathi1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2017年2月8日最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
40
试验地点
1
主要终点
Therapeutic efficacy of Siru nerunjil kudineer on KALLADAIPPU

研究概览

简要总结

The study is prospective open Labeled randomized phase II clinical trial to evaluate the therapeutic efficacy of trial drug Siru nerunjil kudineer 40ml Bd for 30 days on the 40 patients with KALLADAIPPU that will be conducted in Government Siddha Medical college and hospital Palayamkottai The primary outcome will be the therapeutic efficacy of trial drug Sirunerunjil kudineer The secondary outcome will be the evaluation of Siddha diagnostic parameters

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
20.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patient with appropriate symptoms of renal colic pain nausea or vomiting haematuria oliguria dysuria excessive sweating Patient who are willing to sign consent form and undergo laboratory investigations.

排除标准

  • Pregnant and lactating women Diabetes mellitus Chronic appendicitis Pyelonephritis Cholecystitis Systemic hypertension Recurrent UTI Chronic kidney disease Bilateral obstructive uropathy.

结局指标

主要结局

Therapeutic efficacy of Siru nerunjil kudineer on KALLADAIPPU

时间窗: 30 days

次要结局

  • Evaluation of Siddha diagnostic parameters(30 days)

研究者

发起方
S Neelavathi
申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验